Let's keep in mind that the business is drug development in a regulated environment. This will take time. In major pharma, measured in years and years but luckily here measured in quarters for the Macular Degeneration Metformin treatment. I expect one or two big news events by the end of the year that announce the trial design and the lead investigator. Those will be material but anyone watching this company knows they will not waste time or money announcing trivial items.
News 
Market Data 
Discover 
